The concept of tissue targeting depends upon unique expression or overexpression of specific ligands on the cell surface; for example, vascular endothelial growth factor receptor (VEGF) and integrins expression on the tumor cell surface have been used as a target for nanovectors through coating the surface of the nanovectors with peptides, thioaptamers, carbohydrates or antibodies. Here, VEGFA is linked to neoplasm.